Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1969 2
1970 1
1971 2
1977 1
1982 1
1983 1
1986 1
1989 1
1990 1
1991 1
1993 1
1994 2
1999 1
2000 1
2002 1
2003 1
2005 1
2006 2
2007 3
2008 3
2009 1
2010 2
2011 4
2012 3
2013 8
2014 6
2015 12
2016 8
2017 1
2018 6
2019 5
2020 6
2021 3
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Heart Failure.
Kitchens J, Maze L. Kitchens J, et al. Crit Care Nurs Clin North Am. 2015 Dec;27(4):xi-xii. doi: 10.1016/j.cnc.2015.09.001. Epub 2015 Sep 16. Crit Care Nurs Clin North Am. 2015. PMID: 26567501 No abstract available.
Reducing Nursing Specimen Collection Errors.
Embree JL, Onuorah E, Kitchens J, Smith C, Hazlett T, Arebun J. Embree JL, et al. Among authors: kitchens j. J Contin Educ Nurs. 2020 Oct 1;51(10):450-452. doi: 10.3928/00220124-20200914-05. J Contin Educ Nurs. 2020. PMID: 32976612
Patient Safety Coalition: A Focus on Heart Failure.
Kitchens J, Kingery J, Fuller JH, Nazir A. Kitchens J, et al. Crit Care Nurs Clin North Am. 2015 Dec;27(4):523-35. doi: 10.1016/j.cnc.2015.07.001. Epub 2015 Sep 26. Crit Care Nurs Clin North Am. 2015. PMID: 26567496 Review.
External Choroidal Drainage Using Direct Visualization.
Snyder LL, Kitchens JW, Patel SN. Snyder LL, et al. Among authors: kitchens jw. Ophthalmic Surg Lasers Imaging Retina. 2019 Aug 1;50(8):529-531. doi: 10.3928/23258160-20190806-11. Ophthalmic Surg Lasers Imaging Retina. 2019. PMID: 31415703
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
97 results